SRZN — Surrozen Income Statement
0.000.00%
Last trade - 00:00- $84.29m
- $49.73m
- $10.66m
Annual income statement for Surrozen, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 0 | 12.5 | 0 | 10.7 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 32.8 | 54.4 | 56.8 | 45.8 | 36.2 |
| Operating Profit | -32.8 | -54.4 | -44.3 | -45.8 | -25.5 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -32.7 | -54.6 | -36 | -43 | -63.6 |
| Net Income After Taxes | -32.7 | -54.6 | -36 | -43 | -63.6 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -32.7 | -54.6 | -36 | -43 | -63.6 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -32.7 | -54.6 | -36 | -43 | -63.6 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -14 | -23.4 | -15.6 | -19.8 | -21.7 |
| Dividends per Share |